Our attorneys have filed a mass tort lawsuit on behalf of individuals who took the blood thinner Xarelto
(rivaroxaban) and suffered significant bleeding events. Pharmaceutical firms, like the makers of Xarelto, possess a duty to ensure that their drugs are reasonably secure for use - and failure to accomplish so might be grounds for compensation. Our lawyers are operating challenging to have those hurt by the drug the compensation they're entitled to.
While bleeding can be a frequent complication associated with anticoagulants, it has been alleged that Xarelto is a lot more dangerous than conventional blood thinners due to the fact no antidote exists to reverse its blood-thinning effects. This signifies that, in the event of an emergency, patients could be at danger for irreversible bleeding troubles, which includes life-threatening internal and gastrointestinal hemorrhaging.
Should you or even a loved a single suffered a critical bleeding event after taking Xarelto, you might have legal recourse. For more info, make contact with us right now to have your case reviewed, cost-free of charge.
xarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future health-related bills, lost wages, pain and suffering and, in cirstances of death, funeral expenditures. Moreover, they may be looking for punitive damages, which are generally awarded to punish the defendant and deter other businesses from acting similarly.
Why Are Lawsuits Being Filed?
Bayer and Johnson & Johnson_s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is hazardous and defective. The plaintiffs claim that, unlike classic anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Due to the fact of this, the lawsuits claim, doctors have no effective signifies of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, which includes cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.
In addition to these risks, lawsuits against Bayer and Johnson & Johnson_s Janssen Pharmaceuticals are alleging:
The manufacturers of Xarelto marketed the drug as a superior within the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.
The makers of the drug continue to market Xarelto as a protected anticoagulant option.
Doctors and medical staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.
Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.
Xarelto is linked to significant bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.
Visit this page for far more details on the alleged health risks of Xarelto.
Multidistrict Litigation Trial Dates Set
The attorneys in the Complex Litigation Group have a peek at this website
filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.